CytomX Therapeutics (CTMX) Stock Price & Financial Analysis
CytomX Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About CytomX Therapeutics
What is the current stock price for CTMX?
As of the latest trading session, CTMX stock trades at $4.56. The 52-week range is $0.40–$8.21, with a day range of $4.29–$4.58.
What is the P/E ratio for CTMX?
CytomX Therapeutics's trailing P/E ratio is 26.9, meaning investors pay $26.9 for every $1 of annual earnings. The forward P/E is 13.4, reflecting analyst expectations for future earnings. CytomX Therapeutics operates in the Healthcare sector.
Does CTMX pay dividends?
CytomX Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTMX?
Based on 8 analysts, the consensus for CTMX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CTMX?
CytomX Therapeutics's market capitalization is $752.4M, classifying it as a small-cap company. CytomX Therapeutics operates in the Healthcare sector within the Biotechnology industry.